Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/13/2025 | $35.00 | Buy | The Benchmark Company |
| 9/24/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 5/30/2024 | $20.00 | Market Perform → Outperform | Noble Capital Markets |
| 4/5/2024 | $25.00 | Buy | Lake Street |
| 3/27/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 2/26/2024 | $14.00 | Market Perform → Outperform | Noble Capital Markets |
| 11/27/2023 | Outperform → Market Perform | Noble Capital Markets | |
| 11/14/2023 | $13.00 | Market Perform → Outperform | Noble Capital Markets |
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
3 - Lifeway Foods, Inc. (0000814586) (Issuer)
The Benchmark Company initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $35.00
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00
Highlights ISS concerns around Lifeway's governance, board practices and composition CHICAGO, Dec. 19, 2025 /PRNewswire/ -- Edward Smolyansky, largest individual shareholder of Lifeway Foods, Inc. (NASDAQ:LWAY), today drew attention to critical governance concerns identified by Institutional Shareholder Services ("ISS") in its recent proxy analysis. Mr. Smolyansky's full letter to the shareholders can be accessed here. In its report, ISS questioned Lifeway's approach to shareholder and proxy advisor engagement, noting that governance-related discussions were not led by the CEO or any incumbent director, but instead by the Company's Chief of Staff—who is also the spouse of CEO Julie Smolyans
MORTON GROVE, Ill., Dec. 18, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company") a leading U.S. supplier of kefir and fermented dairy products, today announced that Institutional Shareholder Services ("ISS") has recommended that shareholders vote FOR all of the Company's director nominees (the "Board Nominees") and WITHHOLD votes from nominees submitted by Edward Smolyansky (the "Dissident Nominees") at Lifeway's upcoming 2025 Annual Meeting of Shareholders, scheduled for December 29, 2025, as set forth below: Name ISS Recommendation BOARD NOMIN
CHICAGO, Dec. 15, 2025 /PRNewswire/ -- Edward Smolyansky, largest individual shareholder and nominee for director of Lifeway Foods, Inc. (Nasdaq: LWAY), released key findings from 2023 sworn deposition highlighting major governance breakdowns under then CEO/Chair Julie Smolyansky and the failure of legacy directors, Dorri McWhorter (current Board Chairperson) and Jason Scher to hold management accountable, ahead of the crucial shareholder decision. The following summary draws solely from Ms. McWhorter's sworn deposition testimony and highlights why shareholders should WITHHOLD
DEFR14A - Lifeway Foods, Inc. (0000814586) (Filer)
EFFECT - Lifeway Foods, Inc. (0000814586) (Filer)
424B3 - Lifeway Foods, Inc. (0000814586) (Filer)
Calls on Industry Partners to Join in Building a New Model for Public Health, Farmers,and Consumers MORTON GROVE, Ill., June 17, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products, today announced that CEO Julie Smolyansky is launching an open industry-wide conversation to explore the creation of a new voluntary dairy certification standard. The proposal is designed to balance public health, consumer demand, and farmer viability — and to create a new model of trust and transparency in the dairy marketplace. The announcement is one of many initiatives coming from Lifeway Foods as part of their 40th anniversary plans and
Achieves $57.1 million in net sales, a 29% volume-led net sales increase on a comparable basis, driven by the Company's flagship Lifeway Kefir Record-breaking quarter marks six years of uninterrupted quarterly net sales growth Significant gross margin expansion of 300 basis points and net income growth of 19% reflects the Company's disciplined operational execution MORTON GROVE, Ill., Nov. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for the third quarter ended September 30, 2025.
MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sect
Kefir market leader posts $53.9 million in net sales, an 18% volume-led net sales increase on a comparable basis, marking nearly six years of uninterrupted net sales growth Company posts double-digit diluted EPS gains and strong gross margin expansion year-over-year Momentum accelerates into Q3 with highest weekly sales ever recorded in July and unaudited estimate of $26.4 million in net sales for the third quarter-to-date through August 11, up over 20% year-over-year MORTON GROVE, Ill., Aug. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for th
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)